Freestone Grove Partners LP Balchem Corp Transaction History
Freestone Grove Partners LP
- $13.2 Trillion
- Q2 2025
A detailed history of Freestone Grove Partners LP transactions in Balchem Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 3,320 shares of BCPC stock, worth $483,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,320Holding current value
$483,325% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCPC
# of Institutions
426Shares Held
28.9MCall Options Held
64.8KPut Options Held
6.2K-
Black Rock Inc. New York, NY4.9MShares$714 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$567 Million0.01% of portfolio
-
State Street Corp Boston, MA1.23MShares$178 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.15MShares$167 Million2.72% of portfolio
-
Geode Capital Management, LLC Boston, MA981KShares$143 Million0.01% of portfolio
About BALCHEM CORP
- Ticker BCPC
- Exchange NASDAQ
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 32,120,600
- Market Cap $4.68B
- Description
- Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...